196 related articles for article (PubMed ID: 31012504)
41. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
42. Radiosensitization to X-ray radiation by telomerase inhibitor MST-312 in human hepatoma HepG2 cells.
Wang Y; Sun C; Mao A; Zhang X; Zhou X; Wang Z; Zhang H
Life Sci; 2015 Feb; 123():43-50. PubMed ID: 25596016
[TBL] [Abstract][Full Text] [Related]
43. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
[TBL] [Abstract][Full Text] [Related]
44. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
45. Telomeres and telomerase: from discovery to clinical trials.
Corey DR
Chem Biol; 2009 Dec; 16(12):1219-23. PubMed ID: 20064431
[TBL] [Abstract][Full Text] [Related]
46. 1,3,4-Oxadiazoles as Telomerase Inhibitor: Potential Anticancer Agents.
Bajaj S; Roy PP; Singh J
Anticancer Agents Med Chem; 2018 Feb; 17(14):1869-1883. PubMed ID: 28443517
[TBL] [Abstract][Full Text] [Related]
47. Berberine Inhibits Telomerase Activity and Induces Cell Cycle Arrest and Telomere Erosion in Colorectal Cancer Cell Line, HCT 116.
Samad MA; Saiman MZ; Abdul Majid N; Karsani SA; Yaacob JS
Molecules; 2021 Jan; 26(2):. PubMed ID: 33450878
[TBL] [Abstract][Full Text] [Related]
48. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
Maji B; Bhattacharya S
Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755
[TBL] [Abstract][Full Text] [Related]
49. [Suppression of alternative telomere lengthening in cancer cells with reverse transcriptase inhibitors].
Bondarev IE; Khavinson VK
Adv Gerontol; 2016; 29(2):218-221. PubMed ID: 28514537
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.
Herbert B; Pitts AE; Baker SI; Hamilton SE; Wright WE; Shay JW; Corey DR
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14276-81. PubMed ID: 10588696
[TBL] [Abstract][Full Text] [Related]
51. Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
Smith V; Dai F; Spitz M; Peters GJ; Fiebig HH; Hussain A; Burger AM
J Chemother; 2009 Nov; 21(5):542-9. PubMed ID: 19933046
[TBL] [Abstract][Full Text] [Related]
52. Telomerase and telomeres: from basic biology to cancer treatment.
Helder MN; Wisman GB; van der Zee GJ
Cancer Invest; 2002; 20(1):82-101. PubMed ID: 11855380
[TBL] [Abstract][Full Text] [Related]
53. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C
Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149
[TBL] [Abstract][Full Text] [Related]
54. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
55. Telomerase as an anti-cancer target: current status and future prospects.
Neidle S; Kelland LR
Anticancer Drug Des; 1999 Aug; 14(4):341-7. PubMed ID: 10625926
[TBL] [Abstract][Full Text] [Related]
56. Telomerase Inhibitors from Natural Products and Their Anticancer Potential.
Ganesan K; Xu B
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267203
[TBL] [Abstract][Full Text] [Related]
57. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.
Chen X; Zha GF; Wang JQ; Liu XH
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286
[TBL] [Abstract][Full Text] [Related]
58. Telomerase activity in pleural malignant mesotheliomas.
Au AY; Hackl T; Yeager TR; Cohen SB; Pass HI; Harris CC; Reddel RR
Lung Cancer; 2011 Sep; 73(3):283-8. PubMed ID: 21277646
[TBL] [Abstract][Full Text] [Related]
59. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
Min J; Wright WE; Shay JW
Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
[TBL] [Abstract][Full Text] [Related]
60. Targeting the telosome: therapeutic implications.
Folini M; Gandellini P; Zaffaroni N
Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]